Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Nanobiosensors for Rheumatoid Arthritis Biomarkers: Advances and Clinical Translational Potential.

International journal of nanomedicine·2026
Same author

Molecular Chelating-Clamp Strategy Using Dithiol Antidotes Enables Efficient and Stable Inorganic Perovskite Solar Cells.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Comparison of three surgical methods in the treatment of displaced intra-articular calcaneal fractures: A retrospective study.

Injury·2026
Same author

Characterization of a lytic polysaccharide monooxygenase important for utilization of chitin in Chitinibacter mangrovi FCG-7.

International journal of biological macromolecules·2026
Same author

Sulfur-Mediated Charge Delocalization Enables High-Voltage p-Type Polymer Cathodes for Ultralow-Temperature Potassium Dual-Ion Full Cells.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

One-step enzymatic synthesis of medium molecular weight dextran using engineered dextransucrase DarM from <i>Leuconostoc citreum</i> CBA3623.

Frontiers in microbiology·2026

相关实验视频

Updated: Sep 8, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K

通过合理的抑制剂设计和组合疗法克服RET改变的癌症的耐药性

Ting Wang1, Wenjie Jiang1, Liyan Yang1

  • 1Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Bioorganic chemistry
|September 6, 2025
PubMed
概括

针对RET的疗法正在超越传统的多酶抑制剂以克服癌症药物耐药性. 新型抑制剂和组合策略在RET驱动的癌症中有望提高疗效和安全性.

关键词:
组合疗法药物耐药性的机制精确的药物开发RET 抑制剂

更多相关视频

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.3K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K

相关实验视频

Last Updated: Sep 8, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.3K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K

科学领域:

  • 癌症学
  • 分子生物学
  • 药物发现

背景情况:

  • RET氨酸激酶是癌症中关键的信号调节剂,通常因突变或融合而失调.
  • 传统的多酶抑制剂 (MKIs) 由于目标外毒性和获得的耐药性突变而面临限制.
  • 第二代RET抑制剂提供了更好的选择性和血脑屏障透,但仍然遇到阻力.

研究的目的:

  • 审查RET向癌症治疗的进展.
  • 阐明对RET抑制剂耐药性的机制.
  • 探索克服抗药性并改善治疗结果的新方法.

主要方法:

  • 对RET抑制剂开发和临床试验的当前文献分析.
  • 对抗机制的审查,包括特定的RET突变和绕道信号通路.
  • 评估新的治疗策略,如多向抑制剂,结构改造,天然化合物和组合疗法.

主要成果:

  • 第二代RET抑制剂表现出增强的疗效和安全性,在大脑转移中具有显著的活性.
  • 药物耐药性源于溶剂前端突变和替代信号通路的激活.
  • 新兴的策略,如多目标抑制,结构优化和组合疗法 (例如,塞尔珀卡提尼布与克里佐替尼布,三氧化与普拉塞提尼布) 显示出克服耐药性的潜力.
  • 像SY-5007这样的新药在RET融合阳性非小细胞肺癌中表现出显著的反应率.

结论:

  • 持续开发具有高度选择性和广泛的RET抑制剂至关重要.
  • 个性化组合治疗方案对于改善患者预后至关重要.
  • 这一审查为未来针对RET的精密瘤药物开发提供了框架.